TITLE

Current options in prosthetic vascular graft infection

AUTHOR(S)
Henke, Peter K.; Bergamini, Thomas M.; Rose, Scott M.; Richardson, J. David
PUB. DATE
January 1998
SOURCE
American Surgeon;Jan1998, Vol. 64 Issue 1, p39
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Evaluates outcome of treatment on patients with prosthetic vascular graft infections. Patients and methods utilized on the study; Alternative strategies that have emerged to circumvent vascular graft infection; Recovered organisms in patients used on the study.
ACCESSION #
230542

 

Related Articles

  • Vascular and Cardiac Surgery I.  // European Surgical Research;1999 Supplement 1, Vol. 31, p136 

    Presents a summary of studies on Vascular and Cardiac Surgery I from the journal European Surgical Research. Effect of prevention of neointimal proliferation by immunosuppression in synthetic vascular grafts; Result of balloon angioplasty and stenting in mechanically reconstructed arteries;...

  • Nocardia Infection in Heart-Lung Transplant Recipients at Alfred Hospital, Melbourne, Australia... Roberts, S. A.; Franklin, J. C.; Spelman, D. // Clinical Infectious Diseases;10/1/2000, Vol. 31 Issue 4, p968 

    Reports on Nocardia infections or nocardiosis in patients undergoing lung-heart transplantations at Alfred Hospital in Melbourne, Victoria. Factors that increase the risk of Nocardia infection in the group; Frequency of occurrence on infection; Susceptibility of all isolates to...

  • Histoplasmosis in Solid Organ Transplant Recipients. Hage, Chadi; Kleiman, Martin B.; Wheat, L. Joseph // Clinical Infectious Diseases;1/1/2010, Vol. 50 Issue 1, p122 

    A letter to the editor is presented in response to the article "Histoplasmosis in Solid Organ Transplant Recipients," by J. Cuellar-Rodriguez and colleagues.

  • Reply to Hage et al. Cuellar-Rodriguez, J.; Avery, R. K.; Lard, M.; Budev, M.; Gordon, S. M.; Shrestha, N. K.; van Duin, D.; Mawhorter, S. D. // Clinical Infectious Diseases;1/1/2010, Vol. 50 Issue 1, p123 

    A response by J. Cuellar-Rodriguez and colleagues to a letter to the editor about their article "Histoplasmosis in Solid Organ Transplant Recipients" is presented.

  • Visceral Leishmaniasis (Kala-azar) in Solid Organ Transplantation: Report of Five Cases and Review. Hernaacutendez-Peacuterez, J.; Yebra-Bango, M.; Jimeacutenez-Martinez, E.; Sanz-Moreno, C.; Cuervas-Mons, V.; Alonso Pulpón, L.; Ramos-Martínez, A.; Fernaacutendez-Fernaacutendez, J. // Clinical Infectious Diseases;10/1/1999, Vol. 29 Issue 4, p918 

    Presents information on several case studies of visceral leishmaniasis in recipients of solid organ grafts. Background of the illness; Clinical history of the patients; Treatment.

  • Preemptive Therapy Versus Universal Prophylaxis with Ganciclovir for Cytomegalovirus in Solid Organ Transplant Recipients. Singh, Nina // Clinical Infectious Diseases;3/1/2001, Vol. 32 Issue 5, p742 

    Compares the effectiveness of preemptive therapy and universal prophylaxis with ganciclovir for treating cytomegalovirus in solid organ transplant recipients. Availability of preemptive therapy tools; Adverse effects of prophylaxis; Cost-effectiveness of the approaches.

  • Human Herpesviruses 6 and 7 in Solid Organ Transplant Recipients. Snydman, David R.; Emery, Vincent C. // Clinical Infectious Diseases;5/1/2001, Vol. 32 Issue 9, p1357 

    Focuses on a study which discussed the impact of human herpesviruses 6 and 7 (HHV-6 and HHV-7) on solid organ transplant patients. Background information on the viruses; Details on the antiviral chemotherapy for HHV-6 and HHV-7; Explanations on monitoring for HHV-6 and HHV-7 after organ...

  • Management of Cytomegalovirus Infection and Disease after Solid-Organ Transplantation. van der Bij, Wire; Speich, Rudolf // Clinical Infectious Diseases;7/1/2001 Supplement 1, Vol. 33, pS32 

    Discusses the considerable progress that has been made in elucidating risk factors for cytomegalovirus (CMV) infection in organ transplantation patients. Pathophysiology of CMV infection; Diagnosis; Prevention; Treatment.

  • Epidemiology and Management of Infections after Lung Transplantation. Speich, Rudolf; van der Bij, Wire // Clinical Infectious Diseases;7/1/2001 Supplement 1, Vol. 33, pS58 

    Discusses the epidemiology and treatment of infectious complications after lung transplantation. Pathogens which typically causes infections after lung transplantation; Microbiologic surveillance of the lung donor and recipients; Double-lung transplantation in patients with lung cystic fibrosis.

  • Coccidioidomycosis in Solid Organ Transplantation. Blair, Janis E.; Logan, Joy L. // Clinical Infectious Diseases;11/1/2001, Vol. 33 Issue 9, p1536 

    Provides information on coccidioidomycosis, an endemic fungal infection related to solid organ transplantation. Demographic characteristics of patients with coccidioidomycosis; Incidence of coccidioidomycosis after transplantation; Risk factors for coccidioidomycosis; Clinical manifestation of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics